ArticleSubstance abuse treatment, prevention, and policy2026
Profiles of care trajectories among patients with substance-related disorders, assessed over nine years considering other patient characteristics and subsequent adverse outcomes.
Article in Substance abuse treatment, prevention, and policy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThis study is original in that it identified the care trajectories of patients with substance-related disorders (SRDs) over a 9-year period, and associated these trajectories with the patients' sociodemographic and clinical characteristics, quality of care received, and subsequent adverse outcomes (high emergency department use, repeated hospitalizations, suicidal behaviors, death).
methodsHealth administrative databases from Quebec, Canada (1996-2022) were used to investigate a cohort of 4075 patients with SRDs. Group-based multi-trajectory modeling was produced to identify profiles of care trajectories from April 1st 2012 to March 31st 2021. Multinomial regressions and survival analysis were conducted to associate profiles to patient characteristics, and adverse outcomes over the following year.
resultsFive profiles of care trajectories were identified: "Low overall but increasing care use" (Profile 1, 30% of sample); "High, increasing outpatient physical health care use" (Profile 2, 26%); "High, increasing outpatient SRD care use" (Profile 3, 15%); "High overall care use" (Profile 4, 14%); and "Increasing but moderate outpatient care use" (Profile 5, 15%). Profiles 3 and 4 used substantially more SRD outpatient care. Patients in Profiles 4 and 5 had more complex health conditions and engaged in more varied, sustained care over time, but subsequently experienced the worst adverse outcomes. In contrast, Profile 1 patients had better overall health conditions, followed by Profile 2 (older at SRD onset, less materially deprived) and 3 (more SRD issues), which both exhibited higher continuity of care than Profile 1. Profile 3 had the lowest rate of treatment dropouts.
conclusionUse of care and adverse outcomes were strongly linked to the patients' clinical conditions. Tailored interventions may be recommended for each profile: outreach and motivational interventions for Profile 1; applying the chronic care model for Profile 2; high continuity of physician and SRD care for Profile 3; assertive community treatment for Profile 4; and intensive case management for Profile 5. To better address the unmet needs of patients with SRDs, overall outpatient services may be substantially consolidated and improved. Acute care providers and general practitioners may also play a key role in identifying patients with SRDs and referring them to appropriate outpatient services.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.